- Home
- VRNT vs PLSE Comparison
VRNT vs PLSE Comparison
Compare VRNT & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNT
- PLSE
- Stock Information
- Founded
- VRNT 1994
- PLSE 2014
- Country
- VRNT United States
- PLSE United States
- Employees
- VRNT N/A
- PLSE N/A
- Industry
- VRNT EDP Services
- PLSE Medical/Dental Instruments
- Sector
- VRNT Technology
- PLSE Health Care
- Exchange
- VRNT Nasdaq
- PLSE Nasdaq
- Market Cap
- VRNT N/A
- PLSE 1.3B
- IPO Year
- VRNT N/A
- PLSE 2016
- Fundamental
- Price
- VRNT $22.09
- PLSE $15.85
- Analyst Decision
- VRNT Buy
- PLSE
- Analyst Count
- VRNT 7
- PLSE 0
- Target Price
- VRNT $35.67
- PLSE N/A
- AVG Volume (30 Days)
- VRNT 704.9K
- PLSE 172.8K
- Earning Date
- VRNT 03-26-2025
- PLSE 05-06-2025
- Dividend Yield
- VRNT N/A
- PLSE N/A
- EPS Growth
- VRNT 2980.37
- PLSE N/A
- EPS
- VRNT 0.95
- PLSE N/A
- Revenue
- VRNT $920,749,000.00
- PLSE N/A
- Revenue This Year
- VRNT $4.50
- PLSE N/A
- Revenue Next Year
- VRNT $4.50
- PLSE N/A
- P/E Ratio
- VRNT $22.77
- PLSE N/A
- Revenue Growth
- VRNT 4.45
- PLSE N/A
- 52 Week Low
- VRNT $20.67
- PLSE $6.60
- 52 Week High
- VRNT $38.17
- PLSE $25.00
- Technical
- Relative Strength Index (RSI)
- VRNT 44.38
- PLSE 33.47
- Support Level
- VRNT $21.33
- PLSE $15.57
- Resistance Level
- VRNT $22.76
- PLSE $16.99
- Average True Range (ATR)
- VRNT 0.70
- PLSE 0.99
- MACD
- VRNT 0.14
- PLSE -0.05
- Stochastic Oscillator
- VRNT 65.91
- PLSE 26.21
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.